Cargando…
Safinamide protects against amyloid β (Aβ)-induced oxidative stress and cellular senescence in M17 neuronal cells
Alzheimer’s disease (AD) is a neurodegenerative disorder that is pathologically related to oxidative stress and cellular senescence. Safinamide is one of the clinically prescribed monoamine oxidase B (MAOB) inhibitors. It has been reported to possess therapeutic potential in neurological disorders....
Autores principales: | Gu, Xunhu, Zhang, Ge, Qin, Zhengfang, Yin, Min, Chen, Weiping, Zhang, Yangbo, Liu, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805854/ https://www.ncbi.nlm.nih.gov/pubmed/35001806 http://dx.doi.org/10.1080/21655979.2021.2022262 |
Ejemplares similares
-
Interleukin-1β Drives Cellular Senescence of Rat Astrocytes Induced by Oligomerized Amyloid β Peptide and Oxidative Stress
por: Shang, Dongsheng, et al.
Publicado: (2020) -
The effects of safinamide on dysphagia in Parkinson’s disease
por: Hirano, Makito, et al.
Publicado: (2023) -
Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease
por: Wei, Zhen, et al.
Publicado: (2016) -
Is senescence-associated β-galactosidase a marker of neuronal senescence?
por: Piechota, Malgorzata, et al.
Publicado: (2016) -
Glycation exacerbates the neuronal toxicity of β-amyloid
por: Li, X-H, et al.
Publicado: (2013)